K Number
K210510
Date Cleared
2021-08-12

(171 days)

Product Code
Regulation Number
878.4040
Reference & Predicate Devices
Predicate For
N/A
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
Intended Use

The Disposable Surgical Gown is intended to be worn by operating room personnel during surgical procedures to protect the surgical patient and operating room personnel from the transfer of microorganisms, body fluids and particulate material. In addition, this surgical gown meets the requirements of AAMI Level 3 barrier protection for a surgical gown per ANSI/AAMI PB70:2012 Liquid barrier performance and classification of protective apparel and drapes intended for use in health care facilities (AAMI PB70). The Disposable Surgical Gowns are single use, disposable medical devices, provided sterile.

Device Description

The Disposable Surgical Gown is composed of collar, body, sleeve and tie. The back is full opening, the neck and waist are laced, the sleeve are made of polyester elastic closure by sewing, and the rest are made of heat sealing. It has been tested according to AAMI PB70:2012 and meet AAMI Level 3 barrier level protection for a surgical gown

AI/ML Overview

This document is a 510(k) Premarket Notification from the FDA regarding a Disposable Surgical Gown. It evaluates the device's substantial equivalence to a legally marketed predicate device. The information provided is about the physical and performance characteristics of a surgical gown, not a diagnostic AI device requiring complex clinical studies or expert ground truth.

Therefore, many of the requested categories for AI/diagnostic device evaluation (like sample size for test sets, data provenance, number of experts, adjudication methods, MRMC studies, standalone performance, ground truth for training) are not applicable to this type of medical device submission.

The "acceptance criteria" for this device are defined by a series of standardized non-clinical tests that measure physical properties and barrier performance.

Here's the relevant information based on the provided text:

1. Table of Acceptance Criteria and Reported Device Performance

Test MethodologyPurposeAcceptance CriteriaResults
AATCC 42Impact PenetrationLevel 3, ≤1.0g<0.1g
AATCC 127Hydrostatic ResistanceLevel 3, ≥50cm>70 cm for critical zone
ASTM D5034Tensile strengthMachine direction mean: ≥18 lbf; Cross direction mean: ≥12 lbf.Machine direction mean: 21.95 lbf; Cross direction mean: 14.41 lbf.
ASTM D5587Tear resistanceFabric direction A mean: ≥4.0 lbf; Fabric direction B mean: ≥2.5 lbf;Fabric direction A mean: 5.09 lbf; Fabric direction B mean: 3.10 lbf;
ASTM D1683Seam strengthShoulder: ≥8.5 lbf; Arm opening: ≥5.5 lbf; Sleeve: ≥8.5 lbf;Shoulder: 10.8 lbf; Arm opening: 6.4 lbf; Sleeve: 10.2 lbf;
ISO 9073-10Side A (outside) IPMIndex for Particulate Matter (IPM): ≤2.5Index for Particulate Matter (IPM): 2.25
ISO 9073-10Side B (inside) IPMIndex for Particulate Matter (IPM): ≤3.0Index for Particulate Matter (IPM): 2.85
ISO 9073-10Side A&B IPMIndex for Particulate Matter (IPM): ≤3.0Index for Particulate Matter (IPM): 2.64
ASTM F2407Evaporative resistanceCritical zone: ≥850 g/m²/24hrs; Non-critical zone: ≥850 g/m²/24hrsCritical zone: 953.8 g/m²/24hrs; Non-critical zone: 930.2 g/m²/24hrs
16 CFR Part 1610Flame spreadClass 1, Non FlammableClass 1, Non Flammable
USP42-NF37 <85>Bacterial Endotoxins< 20EU< 20EU
ISO 11737-2:2019SAL (Sterility Assurance Level)10^-610^-6
BiocompatibilityCytotoxicityUnder the condition of the test, no potential cytotoxicityUnder the condition of the test, no potential cytotoxicity
BiocompatibilityIrritationUnder the condition of the test, no irritationUnder the condition of the test, no irritation
BiocompatibilitySensitizationUnder the condition of the test, no sensitizationUnder the condition of the test, no sensitization

2. Sample size used for the test set and the data provenance:

The document does not specify the exact sample sizes (number of gowns or material samples) used for each physical and performance test. These are standard laboratory tests typically performed on a statistically representative number of samples according to the respective ASTM/ISO standards.

Data Provenance: The device manufacturer is Shandong Zhushi Pharmaceutical Group Co., Ltd in Shandong, China. The testing was non-clinical (laboratory testing of physical properties) and did not involve patient data or retrospective/prospective studies in the sense of a diagnostic AI device.

3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts (e.g. radiologist with 10 years of experience):

Not applicable. The "ground truth" for this device is established by the specifications in the recognized consensus standards (e.g., AAMI PB70:2012, ASTM, ISO standards). The tests themselves are objective measurements of physical and barrier properties, not subjective interpretations requiring human experts for "ground truth."

4. Adjudication method (e.g. 2+1, 3+1, none) for the test set:

Not applicable. This is not a study requiring adjudication of human reader interpretations.

5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance:

Not applicable. This device is not an AI diagnostic tool and does not involve human readers interpreting images.

6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done:

Not applicable. This is a physical medical device (surgical gown), not an algorithm or software. The "standalone" performance is the direct result of the laboratory tests on the gown's material and construction.

7. The type of ground truth used (expert concensus, pathology, outcomes data, etc):

The "ground truth" is defined by established, recognized international and national consensus standards for medical textiles and surgical apparel (e.g., ANSI/AAMI PB70:2012, AATCC, ASTM, ISO standards). These standards specify the acceptable physical and barrier performance characteristics (e.g., tensile strength, hydrostatic resistance, bacterial endotoxin limits) that the device must meet.

8. The sample size for the training set:

Not applicable. This is a physical device, not an AI algorithm requiring a training set.

9. How the ground truth for the training set was established:

Not applicable.

{0}------------------------------------------------

Image /page/0/Picture/0 description: The image shows the logo of the U.S. Food & Drug Administration (FDA). On the left is the Department of Health & Human Services USA logo. To the right of that is the FDA logo, which is a blue square with the letters "FDA" in white. To the right of the blue square is the text "U.S. FOOD & DRUG ADMINISTRATION" in blue.

August 12, 2021

Shandong Zhushi Pharmaceutical Group Co., Ltd % Boyle Wang General Manager Shanghai Truthful Information Technology Co., Ltd. Room 608, No.738, Shangcheng Rd., Pudong Shanghai, Shanghai 200120 China

Re: K210510

Trade/Device Name: Disposable Surgical Gown Regulation Number: 21 CFR 878.4040 Regulation Name: Surgical Apparel Regulatory Class: Class II Product Code: FYA Dated: May 12, 2021 Received: May 12, 2021

Dear Boyle Wang:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

{1}------------------------------------------------

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.

For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE(@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).

Sincerely.

Bifeng Qian -S

For Clarence W. Murray III, Ph.D. Assistant Director DHT4B: Division of Infection Control and Plastic Surgery Devices OHT4: Office of Surgical and Infection Control Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health

Enclosure

{2}------------------------------------------------

Indications for Use

510(k) Number (if known) K210510

Device Name Disposable Surgical Gown

Indications for Use (Describe)

The Disposable Surgical Gown is intended to be worn by operating room personnel during surgical procedures to protect the surgical patient and operating room personnel from the transfer of microorganisms, body fluids and particulate material. In addition, this surgical gown meets the requirements of AAMI Level 3 barrier protection for a surgical gown per ANSI/AAMI PB70:2012 Liquid barrier performance and classification of protective apparel and drapes intended for use in health care facilities (AAMI PB70). The Disposable Surgical Gowns are single use, disposable medical devices, provided sterile.

Type of Use (Select one or both, as applicable)
-------------------------------------------------

| | Prescription Use (Part 21 CFR 801 Subpart D)

X Over-The-Counter Use (21 CFR 801 Subpart C)

CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

{3}------------------------------------------------

510(k) Summary

K210510

This summary of 510(k) safety and effectiveness information is being submitted in accordance with requirements of SMDA 1990 and 21 CFR 807.92.

1.0 Submitter's information

Name: Shandong Zhushi Pharmaceutical Group Co., Ltd Address: No.6 Shande Road, Shan County, Heze City, Shandong, China Contact: Mr. Junhui Zhu Phone Number: 86-530-7150111 Fax number: 86-530-7150111 Date of Preparation: Aug.01, 2021

Designated Submission Correspondent

Mr. Boyle Wang Shanghai Truthful Information Technology Co., Ltd. Room 608, No. 738 Shangcheng Rd., Pudong Shanghai, 200120 China Tel: +86-21-50313932 Email: Info@truthful.com.cn

2.0 Device information

Trade name: Disposable Surgical Gown Common name: Surqical qown Classification name: Gown, Surgical Model(s): XS, S, M, L, XL, XXL, XXXL, XXXXL

3.0 Classification

Production code: FYA Regulation number: 21CFR 878.4040 Classification: Class II Surgical apparel Panel:

4.0 Predicate device information

Manufacturer: Cardinal Health 200, LLC Device: Cardinal Health™ Non-Reinforced Surgical Gown 510(k) number: K170762

5.0 Intended Use/Indication for Use Statement

{4}------------------------------------------------

The Disposable Surgical Gown is intended to be worn by operating room personnel during surgical procedures to protect the surgical patient and operating room personnel from the transfer of microorganisms, body fluids and particulate material. In addition, this surgical gown meets the requirements of AAMI Level 3 barrier protection for a surgical gown per ANSI/AAMI PB70:2012 Liquid barrier performance and classification of protective apparel and drapes intended for use in health care facilities (AAMI PB70). The Disposable Surgical Gowns are single use, disposable medical devices, provided sterile.

6.0 Device description

The Disposable Surgical Gown is composed of collar, body, sleeve and tie. The back is full opening, the neck and waist are laced, the sleeve are made of polyester elastic closure by sewing, and the rest are made of heat sealing. It has been tested according to AAMI PB70:2012 and meet AAMI Level 3 barrier level protection for a surgical gown

Table 3 - General Comparison
ItemProposed devicePredicated deviceRemark
Product CodeFYAFYAIdentical
Regulation No.21 CFR 878.404021 CFR 878.4040Identical
ClassIIIIIdentical
Product nameDisposable Surgical GownCardinal Health™ Non-Reinforced Surgical GownSimilar
510(k) No.K210510K170762Different
ModelsXS, S, M, L, XL, XXL, XXXL, XXXXLM-S, M, L, XL, XXLSimilar
IntendedUse/Indications forUseThe Disposable Surgical Gown isintended to be worn by operatingroom personnel during surgicalprocedures to protect the surgicalpatient and operating roompersonnel from the transfer ofmicroorganisms, body fluids andparticulate material. In addition, thissurgical gown meets therequirements of AAMI Level 3barrier protection for a surgical gownper ANSI/AAMI PB70:2012 Liquidbarrier performance andclassification of protective appareland drapes intended for use inhealth care facilities (AAMI PB70).The Disposable Surgical Gowns aresingle use, disposable medicaldevices, provided sterile.Cardinal Health™Non-Reinforced Surgical Gownis intended to be worn byoperating room personnelduring surgical procedures toprotect the surgical patient andoperating room personnel fromthe transfer of microorganisms,body fluids and particulatematerial. In addition, thissurgical gown meets therequirements of AAMI Level 3barrier protection for a surgicalgown per ANSI/AAMIPB70:2012 Liquid barrierperformance and classificationof protective apparel and drapesintended for use in health careSimilar

7.0Technological Characteristic Comparison Table

{5}------------------------------------------------

facilities (AAMI PB70). The
Cardinal Health™ Non-
Reinforced Surgical Gowns are
single use, disposable medical
devices; provided sterile and
non-sterile.
CompositeNeck Closure: Hook and LoopBelt Ties Knit CuffsTransfer TabNeck Closure: Hook and LoopBelt Ties Knit CuffsTransfer TabIdentical
MaterialPolyolefin (Polypropylene) SMSnonwovenPolyolefin (Polypropylene) SMSnonwovenIdentical
ColorBlueBlueIdentical
SterilitySterileNon-Sterile and sterile* Gap 1
Sterilization methodEOEOIdentical
Shelf life2 yearsNo identified* Gap 2
Single UseYesYesIdentical
Impact Penetration<0.1g0.0-0.10 gSimilar
HydrostaticResistance>70 cm for critical zone65-92 cm* Gap 3
Tensile strengthMachine direction mean: 21.95 lbf;Cross direction mean: 14.41 lbf.MD mean: 21.57 lbf; CD mean:13.6 lbs* Gap 4
Tear resistanceFabric direction A mean: 5.09 lbf;Fabric direction B mean: 3.10 lbf;MD mean: 3.47 lbf; CD mean:5.63 lbs* Gap 5
Flame spreadClass 1, Non FlammableClass 1, Non FlammableIdentical
Resistance to bloodand liquidpenetrationLevel 3 per PB70Level 3 per PB70Identical
CytotoxicityUnder the condition of the test, nopotential cytotoxicityUnder the condition of the test,no potential cytotoxicityIdentical
IrritationSensitizationUnder the condition of the test, noirritation and sensitizationUnder the condition of the test,no irritation and sensitizationIdentical

* Gap analysis:

Gap 1: the proposed device is provided sterile, the predicate device has two types sterile and non sterile, this difference does not create additional risks to the device. Gap 2, the predicate device was not claimed clear shelf life, while the proposed device defined 2 years, the proposed device performed its shelf life study and verified its 2 years shelf life, the difference does not raise additional risk for safety and effectiveness. Gap 3-5, the two devices have some little deviation in product performance, but the difference in the performance test result does not raise additional questions for safety and effectiveness.

8.0 Non-Clinical Test Conclusion

The proposed device was tested and conformed to the related recognized standards and the requirements stated in the "Guidance on Premarket Notification [510(k)] Submissions for Surgical Gowns and Surgical Drapes" dated on August, 1993.

{6}------------------------------------------------

Based on the 6-180 ASTM F2407-06 (Reapproved 2013), the subject device has been conducted the test as following:

AATCC 42-2013 Water Resistance: Impact Penetration Test

AATCC 127-2014 Water Resistance: Hydrostatic Pressure Test

ASTM D5034-09(2017) Standard Test Method for Breaking Strength and Elongation of Texile Fabrics (Grab Test)

ASTM D5587-15(2019) Standard Test Method for Tearing Strength of Fabrics by Trapezoid Procedure

ASTM D1683-17(2018) Standard Test Method for Failure in Sewn Seams of Woven Apparel Fabrics

ASTM F1868-17(2017) Standard Test Method for Thermal and Evaporative Resistance of Clothing Materials Using a Sweating Hot Plate

ISO 9073-10:2003 Textiles - Test methods for nonwovens - Part 10: Lint and other particles generation in the dry state

16 CFR Part 1610(a) Standard for The Flammability of Clothing Textiles

USP42-NF37 <85> Bacterial Endotoxins Test

ISO 11737-2:2019 Sterilization of health care products - Microbiological methods - Part 2: Tests of sterility performed in the definition, validation and maintenance of a sterilization process

TestMethodologyPurposeAcceptance CriteriaResults
AATCC 42ImpactPenetrationLevel 3, ≤1.0g<0.1g
AATCC 127HydrostaticResistanceLevel 3, ≥50cm>70 cm for critical zone
ASTM D5034Tensile strengthMachine direction mean:≥18 lbf;Cross direction mean:≥12 lbf.Machine direction mean:21.95 lbf;Cross direction mean: 14.41lbf.
ASTM D5587Tear resistanceFarbic direction A mean:≥4.0 lbf;Farbic direction B mean:≥2.5 lbf;Farbic direction A mean:5.09 lbf;Farbic direction B mean:3.10 lbf;
ASTM D1683Seam strengthShoulder: ≥8.5 lbf;Arm opening: ≥5.5 lbf;Sleeve: ≥8.5 lbf;Shoulder: 10.8 lbf;Arm opening: 6.4 lbf;Sleeve: 10.2 lbf;
ISO 9073-10Side A (outside)Index for ParticulateMatter (IPM): ≤2.5Index for Particulate Matter(IPM): 2.25
Side B (inside)Index for ParticulateMatter (IPM): ≤3.0Index for Particulate Matter(IPM): 2.85
Side A&BIndex for ParticulateMatter (IPM): ≤3.0Index for Particulate Matter(IPM): 2.64
ASTM 2407EvaporativeresistanceCritical zone: ≥850g/m²/24hrsNon-critical zone: ≥850g/m²/24hrsCritical zone: 953.8g/m²/24hrsNon-critical zone: 930.2g/m²/24hrs
16 CFR PatFlame spreadClass 1, Non FlammableClass 1, Non Flammable

{7}------------------------------------------------

1610
USP42-NF37<85>BacterialEndotoxins< 20EU< 20EU
ISO 11737-2:2019SAL$10^{-6}$$10^{-6}$
CytotoxicityBiocompatibility-cytotoxicityUnder the condition ofthe test, no potentialcytotoxicityUnder the condition of thetest, no potentialcytotoxicity
IrritationBiocompatibility-irritationUnder the condition ofthe test, no irritationUnder the condition of thetest, no irritation
SensitizationBiocompatibility-sensitizationUnder the condition of thetest, no sensitizationUnder the condition of thetest, no sensitization

9.0 Clinical Test Conclusion

No clinical study implemented for the Disposable Surgical Gown.

10.0 Conclusion

The conclusion drawn from the nonclinical tests demonstrates that the subject device in 510(K) submission K210510, the Disposable Surgical Gown is as safe, as effective, and performs as well as or better than the legally marketed predicate device K170762.

§ 878.4040 Surgical apparel.

(a)
Identification. Surgical apparel are devices that are intended to be worn by operating room personnel during surgical procedures to protect both the surgical patient and the operating room personnel from transfer of microorganisms, body fluids, and particulate material. Examples include surgical caps, hoods, masks, gowns, operating room shoes and shoe covers, and isolation masks and gowns. Surgical suits and dresses, commonly known as scrub suits, are excluded.(b)
Classification. (1) Class II (special controls) for surgical gowns and surgical masks. A surgical N95 respirator or N95 filtering facepiece respirator is not exempt if it is intended to prevent specific diseases or infections, or it is labeled or otherwise represented as filtering surgical smoke or plumes, filtering specific amounts of viruses or bacteria, reducing the amount of and/or killing viruses, bacteria, or fungi, or affecting allergenicity, or it contains coating technologies unrelated to filtration (e.g., to reduce and or kill microorganisms). Surgical N95 respirators and N95 filtering facepiece respirators are exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to § 878.9, and the following conditions for exemption:(i) The user contacting components of the device must be demonstrated to be biocompatible.
(ii) Analysis and nonclinical testing must:
(A) Characterize flammability and be demonstrated to be appropriate for the intended environment of use; and
(B) Demonstrate the ability of the device to resist penetration by fluids, such as blood and body fluids, at a velocity consistent with the intended use of the device.
(iii) NIOSH approved under its regulation.
(2) Class I (general controls) for surgical apparel other than surgical gowns and surgical masks. The class I device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to § 878.9.